Search results
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2024 Earnings Call Transcript February 6, 2024...
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Shares Climb 25% But Its Business Is Yet to Catch Up
Simply Wall St. via Yahoo Finance· 1 year agoThose holding Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shares would be relieved that the share...
After a year of 4.1% returns, Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) share price drop last...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock...
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR)...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock...
Arrowhead Pharmaceuticals Inc Insider Sells Shares
GuruFocus.com via Yahoo Finance· 5 months agoChief Discovery/Trans Medicine James Hamilton of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) sold 38,443 shares of the company's stock on January 5,...
Great week for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional investors after losing...
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Institutions' substantial holdings in Arrowhead Pharmaceuticals implies that they have...
Arrowhead Pharmaceuticals Inc Reports Fiscal 2023 Year-End Results
GuruFocus.com via Yahoo Finance· 6 months agoArrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced a net loss of $205.3 million for the fiscal...
Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Arrowhead Pharmaceuticals fair value...
A Look At The Intrinsic Value Of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Simply Wall St. via Yahoo Finance· 1 year agoToday we'll do a simple run through of a valuation method used to estimate the attractiveness of...
Swelling losses haven't held back gains for Arrowhead Pharmaceuticals (NASDAQ:ARWR) shareholders...
Simply Wall St. via Yahoo Finance· 10 months agoIt hasn't been the best quarter for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders,...